Markus Muehlbacher

Functional Inhibitors of Acid Sphingomyelinase (FIASMAs): A Novel Pharmacological Group of Drugs with Broad Clinical Applications

Johannes Kornhuber, Philipp Tripal, Martin Reichel et al. · Cellular Physiology and Biochemistry · 2010 · 362 citations

Life Sciences, Biochemistry, Pharmacology +13

Identification of Novel Functional Inhibitors of Acid Sphingomyelinase

Johannes Kornhuber, Markus Muehlbacher, Stefan Trapp et al. · PLoS ONE · 2011 · 182 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Qualitative prediction of blood–brain barrier permeability on a large and refined dataset

Markus Muehlbacher, Gudrun M. Spitzer, Klaus R. Liedl et al. · Journal of Computer-Aided Molecular Design · 2011 · 158 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Identification of Drugs Inducing Phospholipidosis by Novel in vitro Data

Markus Muehlbacher, Philipp Tripal, Florian Roas et al. · ChemMedChem · 2012 · 65 citations · Full text

Pharmacy, Pharmacology, Toxicology +13

Identification of PPARgamma Partial Agonists of Natural Origin (I): Development of a Virtual Screening Procedure and In Vitro Validation

Laura Guasch, Esther Sala, Anna Castell‐Auví et al. · PLoS ONE · 2012 · 57 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17